Dyne Therapeutics, Inc. DYN Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesAndOtherLiabilities.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s accrued expenses?
- Dyne Therapeutics, Inc. (DYN) reported accrued expenses of $29.21M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s accrued expenses changed year-over-year?
- Dyne Therapeutics, Inc.'s accrued expenses increased by 34.3% year-over-year, from $21.75M to $29.21M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s accrued expenses has grown at a 37.9% compound annual growth rate (CAGR), from $7.53M to $37.55M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.